HIV/AIDS programmes and services should be aware about the potensial and relevant risks regarding the influenza A (H1N1) virus infection as well it needs to consider plans for prevention and treatment. There is lack of information on clinical interactions between HIV and influenza A (H1N1) virus including whose transmission, complications, and spectrum of illness that [...]
Search results for oseltamivir
The CDC Recommendations Use of Influenza A (H1N1) 2009 Monovalent Vaccine
A licensed specific influenza A (H1N1) virus vaccine is being manufactured and expected to be ready in US by mid-October 2009. Since the vaccines might not be enough to supply the demand, herein the CDC recommendation to use these vaccines.
Influenza Antiviral Medication Dosing
Below is a table consist of influenza antiviral medication dosing either Oseltamivir and Zanamivir for Influenza Treatment and Chemoprophylaxis. The table describe the dosing of oseltamivir and zanamivir since Influenza A (H1N1) viruses are sensitive to those medications rather than amantadine and ramantadine.
The Safety of Oseltamivir and Zanamivir for the Treatment and Prevention of Influenza
What you will find in this article are sections discuss about the cause of seasonal influenza, the use of oseltamivir and zanamivir for the treatment of uncomplicated influenza as FDA approval, safety profile of oseltamivir and zanamivir (prophylaxis in adults, treatment in adults and children) including report table of safety outcomes for oral oseltamivir and zanamivir used for treatment and prophylaxis.
